Table III.
Peptides that Induce Responses in CD8+ T Cells of HSV-2 Seropositive Subjects
| ORF | Peptidec | Location in ORF | Subject | HLA-A and -B typesb | Epitope IC50 (μM)d |
|---|---|---|---|---|---|
| UL19 | AFEDRSYPAVFYLLQ | 617–633 | Pt 04 | A01, A03, B08, B63 | 358 |
| UL25 | HNLFLWEDQTLLRAT | 369–383 | Pt 11 | A02, A11, B08, B15 | 2–32 |
| “ | “ | Pt 02 | A02, A34, B35, B62 | ||
| “ | “ | Pt 09 | A01, A02, B08, B44 | ||
| “ | “ | Pt 10 | A02, A24, B35, B44 | ||
| “ | “ | Pt 07 | A02, A03, B07, B44 | ||
| DRLDNRLQLGMLIPG | 405–419 | Pt 12 | A02, A32, B14, B44 | 79–102 | |
| UL46 | RLGPADRRFVALSGS | 249–263 | Pt 13 | A03, B07, B47 | 112 |
| “ | “ | Pt 01 | A03, B07 | ||
| “ | “ | Pt 08 | A01, A03, B07, B08 | ||
| AQREAAGVYDAVRTW | 533–547 | Pt 14 | A03, A68, B35, B53 | 7 (EV9) | |
| “ | “ | Pt 03a | A01, B57 | 216 (GW9) | |
| UL49 | PMRARPRGEVRFLHY | 45–59 | Pt 01 | A03, B07 | 23 |
| “ | “ | Pt 15 | A02, A30, B07, B35 | ||
| “ | “ | Pt 16a | A01, A31, B07, B60 | ||
| “ | “ | Pt 17a | A02, A74, B07, B14 | ||
| “ | “ | Pt 08a | A01, A03, B07, B08 | ||
| “ | “ | Pt 05 | A24, A31, B07, B62 | ||
| ARPRRSASVAGSHGPG | 81–96 | Pt 01 | A03, B07 | 7 | |
| “ | “ | Pt 18 | A02, A68, B07, B14 | ||
| HGPGPARAPPPPGGPV | 93–108 | Pt 01 | A03, B07 | 47 | |
| PKASATPATDPARGR | 129–143 | Pt 01 | A03, B07 | 170 | |
| KNLLQRANELVNPDA | 249–263 | Pt 08 | A01, A03, B07, B08 | 35 | |
| ICP0 | EAGLMDAATPPARPPA | 77–92 | Pt 19 | A24, A30, B18, B40 | 54 |
| LHPFCIPCMKTWIPL | 145–159 | Pt 20 | A01, A03, B07, B08 | 119 | |
| DFIWTGNPRTAPRSL | 209–223 | Pt 13a | A03, B07, B47 | 5 | |
| “ | “ | Pt 07 | A02, A03, B07, B44 | ||
| LPIAGVSSVVALAPY | 689–703 | Pt 21 | A33, A74, B18, B35 | 169 | |
| “ | “ | Pt 10 | A02, A24, B35, B44 | ||
| DMETGHIGAYVVLVD | 717–731 | Pt 06a | A03, A11, B39, B51 | B39 allele not in IEDB | |
| GHIGAYVVLVDQTGN | 721–735 | Pt 22 | A29, A68, B71, B37 | 250. B37/71 not in IEDB | |
| RAAAPAWSRRTLLPE | 741–755 | Pt 01 | A03, B07 | 7 | |
| “ | “ | Pt 07 | A02, A03, B07, B44 | ||
| “ | “ | Pt 05 | A24, A31, B07, B62 | ||
| PVGNMLFDQGTLVGA | 779–793 | Pt 23a | A02, B50, B62 | 2–36 | |
| UL39 | LMLEYFCRCAREESK | 346–359 | Pt 24 | A03, A11, B07, B51 | 710 |
| GVLVHLRIRTREASF | 433–447 | Pt 25a | A02, A03, B49, B62 | 94 | |
| “ | “ | Pt 04 | A01, A03, B08, B63 | 32 | |
| FGGHYMESVFQMYTR | 515–529 | Pt 03 | A01, B57 | 183 | |
| SMSLADFHGEEFEKL | 725–739 | Pt 08a | A01, A03, B07, B08 | 184 | |
| KTSNALCVRGARPFS | 911–925 | Pt 16 | A01, A31, B07, B60 | 17 | |
| UL29 | CPLLIFDRTRKFVLA | 1,013–1,027 | Pt 26a | A24, A34, B14, B50 | Alleles not in IEDB |
Responses to the adjacent downstream 15-mer were also detected,
HLA types in bold text represent those most likely restricting the
epitope response, predicted by commonly shared types, supertype motif conservation and/or
lowest IC50 (smm method) scores using HLA binding prediction programs at IEDB